Pheochromocytoma, a rare tumor causing excessive catecholamine release, leads to severe hypertension and cardiovascular risks, necessitating careful blood pressure management during its surgical removal.

Understanding Pheochromocytoma and Its Risks

Pheochromocytoma is a rare neuroendocrine tumor that originates from chromaffin cells, typically found in the adrenal medulla [2]. Its defining characteristic is the excessive release of catecholamines, which are hormones like adrenaline and noradrenaline [2]. This overproduction of catecholamines often leads to paroxysmal (sudden, episodic) or sustained high blood pressure (hypertension) [2, 4]. While hypertension is a common condition, pheochromocytoma is a less common, but critical, underlying cause that requires specific management [2].

The Dangers of Catecholamine Overload

The sustained or sudden surge of catecholamines in pheochromocytoma can have severe consequences for the cardiovascular system [2, 3]. It can cause damage to the inner lining of blood vessels (vascular endothelial injury), promote the formation of atherosclerotic plaques, and lead to blood vessel spasms (vasospasm) [2]. These effects significantly increase the risk of serious cardiovascular and cerebrovascular events, such as acute myocardial infarction (heart attack) and cerebral infarction (stroke) [2, 4]. In some rare cases, patients may experience both a heart attack and a stroke simultaneously [2]. Other major cardiovascular complications include acute heart failure, severe arrhythmias (irregular heartbeats), and stress-induced cardiomyopathy, also known as Takotsubo syndrome [3]. Takotsubo syndrome is a temporary weakening of the heart muscle that mimics a heart attack but occurs without significant blockages in the coronary arteries, with catecholamine excess playing a central role in its development [3].

Diagnosing a Hidden Cause of Hypertension

Diagnosing pheochromocytoma can be challenging because its symptoms often overlap with more common conditions [2, 3, 4]. Patients might present with symptoms like chest pain, shortness of breath, and palpitations, which can be mistaken for primary hypertension or an acute coronary syndrome [3, 4]. The lack of typical tumor-specific symptoms can lead to misdiagnosis, resulting in inappropriate treatment that does not address the root cause of the problem [2]. For example, a patient might experience dramatic and rapid fluctuations in blood pressure, with sudden surges followed by drops, which can be difficult to manage and may not respond predictably to standard antihypertensive medications [4]. Recurrent headaches and palpitations, especially when associated with poorly controlled hypertension, can also be indicators [3]. Therefore, healthcare providers must consider pheochromocytoma in patients with resistant hypertension, unexplained cardiovascular events, or unusual and severe blood pressure instability [2, 3, 4].

Laparoscopic Adrenalectomy: The Treatment

Once diagnosed, the definitive treatment for pheochromocytoma is surgical removal of the tumor [1]. Laparoscopic adrenalectomy, a minimally invasive surgical procedure, is considered the treatment of choice [1]. This procedure involves removing the affected adrenal gland (or part of it) through small incisions, which typically leads to a quicker recovery compared to traditional open surgery. The goal of surgery is to eliminate the source of excessive catecholamine production, thereby resolving the associated hypertension and preventing further cardiovascular complications.

Navigating Blood Pressure During Surgery

While surgery is curative, managing a patient with pheochromocytoma during the operation presents unique challenges, primarily due to the unpredictable release of catecholamines [1]. During procedures like pneumoperitoneum insufflation (inflating the abdomen with gas for laparoscopic access) and direct handling of the tumor, there is a high risk of a sudden, massive release of catecholamines, leading to a severe hypertensive crisis [1]. Conversely, after the tumor is successfully excised, a common complication is a sudden and severe drop in arterial blood pressure (hypotension) [1]. This can occur because the body's blood vessels, previously constricted by high catecholamine levels, suddenly relax (vasodilation), and any residual effects of antihypertensive medications used before or during surgery can contribute [1]. To manage these dramatic fluctuations, specific medications are used. Clevidipine, an intravenous calcium antagonist, has proven effective in this setting [1]. It acts quickly and has a very short half-life, meaning its effects wear off rapidly [1]. This characteristic is crucial because it allows for precise control of blood pressure peaks during tumor manipulation without contributing to prolonged hypotension once the tumor is removed [1]. Its lack of residual effect makes it a valuable first-choice drug for this type of surgery [1].

Sources

Clevidipine for hypertension treatment in pheochromocytoma surgery. https://pubmed.ncbi.nlm.nih.gov/28958611/
Pheochromocytoma complicated with acute myocardial infarction and cerebral infarction: a case report. https://pubmed.ncbi.nlm.nih.gov/42255217/
Severe Arrhythmia Complicating Takotsubo Cardiomyopathy Revealing an Underlying Pheochromocytoma: A Case Report. https://pubmed.ncbi.nlm.nih.gov/42222622/
A Case Report of Myocardial Infarction Complicated With Blood Pressure Fluctuations Caused by Pheochromocytoma. https://pubmed.ncbi.nlm.nih.gov/42572934/

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.